These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 22882485

  • 21. Forthcoming receptor tyrosine kinase inhibitors.
    Choong NW, Cohen EE.
    Expert Opin Ther Targets; 2006 Dec; 10(6):793-7. PubMed ID: 17105367
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [New concepts in human oncology: is it possible to use them in veterinary medicine as well?].
    Marconato L, Ruess-Melzer K, Buchholz J, Kaser-Hotz B.
    Schweiz Arch Tierheilkd; 2011 Aug; 153(8):351-60. PubMed ID: 21780063
    [Abstract] [Full Text] [Related]

  • 28. No end in sight for telomerase-targeted cancer drugs.
    Williams SC.
    Nat Med; 2013 Jan; 19(1):6. PubMed ID: 23295993
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Fasting plus tyrosine kinase inhibitors in cancer.
    Caffa I, Longo VD, Nencioni A.
    Aging (Albany NY); 2015 Dec; 7(12):1026-7. PubMed ID: 26645151
    [No Abstract] [Full Text] [Related]

  • 34. [Other intracellular tyrosine kinases (including ALK)].
    Mano H.
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():52-6. PubMed ID: 23513811
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Kinases and phosphatases: key enzymes in targeted cancer therapy].
    Schulze M, Gohla A.
    Dtsch Med Wochenschr; 2013 Mar; 138(9):437-40. PubMed ID: 23423940
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Chemotherapy safety in clinical veterinary oncology.
    Klahn S.
    Vet Clin North Am Small Anim Pract; 2014 Sep; 44(5):941-63. PubMed ID: 25174909
    [Abstract] [Full Text] [Related]

  • 39. The discovery of receptor tyrosine kinases: targets for cancer therapy.
    Gschwind A, Fischer OM, Ullrich A.
    Nat Rev Cancer; 2004 May; 4(5):361-70. PubMed ID: 15122207
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.